Not medical advice. This site explains research. It is not a diagnosis, a dose, or a treatment plan.

Mito.newsMito.news
← All articlesEditorial brief · abstract-levelScore 94/100Confidence medium

Inherited ALS risk sits in mitochondrial translation, and end-stage tissue does not copy that pattern

Not medical advice. This brief explains a preprint. It is not a diagnosis, a dose, or a treatment plan.

A gene-set test of the largest European amyotrophic lateral sclerosis genome-wide association study, 27,205 cases and 110,881 controls, found a modest enrichment of inherited risk in mitochondrial translation and the mitoribosome. Genetically predicted expression of individual mitoribosome genes pointed in opposite directions. Expression in post-mortem tissue often did not match that genetic direction, so the abstract leaves cause versus consequence open.

Mito.news · at a glance

Signal profile (abstract-level)

ALS · mitoribosome · mitochondrial translation · SOD1

Score 94/100BIORXIVmedium confidenceALS
94
Importance
87
Mito signal
67
Dysfunction
75
Evidence
50
Translational

Editorial signal profile from the abstract (importance score, mito keywords, dysfunction tags, evidence density, translational cues). Not a figure reproduced from the preprint PDF.

Mitochondria are implicated in amyotrophic lateral sclerosis. This preprint asks which mitochondrial pathways carry inherited risk, and whether the same pathways are a cause of disease or a consequence of it.

The authors tested pathways from the MitoCarta3.0 mitochondrial gene inventory against the largest European genome-wide association study they cite, 27,205 people with ALS and 110,881 people without. Of seven broad categories, only the mitochondrial central dogma remained enriched after correction, with an adjusted P of 0.044. Inside that category, the signal localized to mitochondrial translation (adjusted P 0.008) and the mitoribosome (adjusted P 0.014).

The direction was not one-way. Genetically predicted expression associated higher risk with lower MRPS33, a small-subunit mitochondrial ribosomal protein, and with higher MRPL28, a large-subunit protein. Those genetic directions did not agree with expression changes in ALS tissue more often than chance.

In post-mortem motor cortex from two cohorts, mitochondrial genes were broadly higher in ALS, largely as a global shift. Oxidative phosphorylation subunits and the mitoribosome rose beyond that shift in one consortium's motor cortex (both false-discovery rates 0.027). Oxidative phosphorylation subunits were also enriched in motor neurons made from induced pluripotent stem cells (false-discovery rate 2.4e-8). Spinal cord showed no genome-wide enrichment. A nominal link between an expression cluster and survival in lumbar spinal cord (unadjusted P 0.013) did not leave any single pathway associated with survival after correction.

A nominal enrichment for reactive oxygen species and glutathione metabolism was largely SOD1, superoxide dismutase 1. The abstract does not measure copper or zinc at that enzyme. In post-mortem tissue, nuclear-encoded mitochondrial genes were more negatively co-expressed with genes encoded by mitochondrial DNA than in controls, most strongly in lumbar spinal cord. Stem-cell motor neurons showed the opposite co-expression pattern.

Metal and redox

No iron-sulfur cluster is reported. The only redox gene the abstract isolates is SOD1, and it isolates that gene as the weight behind a nominal glutathione and reactive-oxygen enrichment. That is a genetic attribution, not a measurement of superoxide or of the copper and zinc sites.

What this does not show

Inherited risk and end-stage expression are different observations, and the abstract says they do not line up. Higher oxidative phosphorylation transcripts in dying tissue can be a response, a change in which cells are present, or both. This is a preprint read from the abstract. It is not a mechanism of toxicity and not a treatment claim.

Free HTML is above. Bots pay for JSON at /api/v1/papers/10-64898-2026-11-10-764216. Optional wallet tester: MetaMask ($0.005).

Source preprint

Investigating the causal and consequential role of the nuclear encoded mitochondrial genome in Amyotrophic Lateral Sclerosis

10.64898/2026.11.10.764216

Ali AT, Al Khleifat A, Al-Chalabi A, Hodgkinson A, Iacoangeli A.

Related briefs